Location History:
- Ebetsu, JP (2015)
- Hokkaido, JP (2004 - 2019)
Company Filing History:
7 out of 17 
3 out of 3 
1 out of 1 
Years Active: 2004-2019
Title: Hajime Fujii: Innovator in Proanthocyanidin Oligomers
Introduction
Hajime Fujii is a notable inventor based in Hokkaido, Japan. He has made significant contributions to the field of health products and pharmaceuticals, particularly through his innovative work on proanthocyanidin oligomers. With a total of 7 patents to his name, Fujii's inventions have the potential to impact various industries.
Latest Patents
Fujii's latest patents include a method of producing proanthocyanidin oligomer. This invention relates to a composition that contains proanthocyanidin oligomer, which is bonded with a substance having a phloroglucinol or resorcinol ring structure. The process involves heating plant materials containing proanthocyanidin polymer in an acidic aqueous solution. This method allows for the efficient production of proanthocyanidin oligomers that can be absorbed into the body, which has been a challenge in the past. Another significant patent involves vicenin 2 and its analogues for use as an antispasmodic and/or prokinetic agent. These compositions are designed to provide therapeutic benefits in managing various health conditions.
Career Highlights
Fujii has worked with several companies throughout his career, including Amino Up Chemical Co., Ltd. and Usaien Pharmaceutical Co., Ltd. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in health-related products.
Collaborations
Fujii has collaborated with notable individuals in his field, including Takashi Nakagawa and Buxiang Sun. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his inventions.
Conclusion
Hajime Fujii is a distinguished inventor whose work on proanthocyanidin oligomers and related compounds showcases his commitment to innovation in health products. His contributions have the potential to improve health outcomes and advance pharmaceutical applications.